Ann: NTA: MLN: MLN NAV $0.8095 as at 20/11/12

• Release Date: 22/11/12 16:07
• Summary: NTA: MLN: MLN NAV $0.8095 as at 20/11/12
• Price Sensitive: No
• Download Document  1.45KB

					

MLN
22/11/2012 14:07
NTA

REL: 1407 HRS Marlin Global Limited

NTA: MLN: MLN NAV $0.8095 as at 20/11/12

MLN NAV $0.8095 as at 20/11/12

Date 20/11/2012 13/11/2012
MLN NAV $0.8095 $0.8064
Share price close $0.67 $0.66
Discount 17% 18%

The above NAV is unaudited.

The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).

The five largest portfolio holdings at 20 November 2012 are approximately as
follows:

Biotest (Germany) 6%
Stratec Biomedical (Germany) 4%
Orthofix (United States) 4%
Wirecard (Germany) 4%
Sarin Technologies (Israel) 4%

BACKGROUND
Marlin Global Limited ("Marlin") is a listed investment company that invests
in companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.

For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00230107 For:MLN    Type:NTA        Time:2012-11-22 14:07:35